These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

358 related items for PubMed ID: 22225906

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. PARP3 controls TGFβ and ROS driven epithelial-to-mesenchymal transition and stemness by stimulating a TG2-Snail-E-cadherin axis.
    Karicheva O, Rodriguez-Vargas JM, Wadier N, Martin-Hernandez K, Vauchelles R, Magroun N, Tissier A, Schreiber V, Dantzer F.
    Oncotarget; 2016 Sep 27; 7(39):64109-64123. PubMed ID: 27579892
    [Abstract] [Full Text] [Related]

  • 3. Tissue transglutaminase promotes drug resistance and invasion by inducing mesenchymal transition in mammary epithelial cells.
    Kumar A, Xu J, Brady S, Gao H, Yu D, Reuben J, Mehta K.
    PLoS One; 2010 Oct 12; 5(10):e13390. PubMed ID: 20967228
    [Abstract] [Full Text] [Related]

  • 4. Tissue transglutaminase as a central mediator in inflammation-induced progression of breast cancer.
    Agnihotri N, Kumar S, Mehta K.
    Breast Cancer Res; 2013 Feb 25; 15(1):202. PubMed ID: 23673317
    [Abstract] [Full Text] [Related]

  • 5. Type II transglutaminase stimulates epidermal cancer stem cell epithelial-mesenchymal transition.
    Fisher ML, Adhikary G, Xu W, Kerr C, Keillor JW, Eckert RL.
    Oncotarget; 2015 Aug 21; 6(24):20525-39. PubMed ID: 25971211
    [Abstract] [Full Text] [Related]

  • 6. Transglutaminase Is Required for Epidermal Squamous Cell Carcinoma Stem Cell Survival.
    Fisher ML, Keillor JW, Xu W, Eckert RL, Kerr C.
    Mol Cancer Res; 2015 Jul 21; 13(7):1083-94. PubMed ID: 25934691
    [Abstract] [Full Text] [Related]

  • 7. Transglutaminase 2 reprogramming of glucose metabolism in mammary epithelial cells via activation of inflammatory signaling pathways.
    Kumar S, Donti TR, Agnihotri N, Mehta K.
    Int J Cancer; 2014 Jun 15; 134(12):2798-807. PubMed ID: 24477458
    [Abstract] [Full Text] [Related]

  • 8. Epithelial-mesenchymal transition can suppress major attributes of human epithelial tumor-initiating cells.
    Celià-Terrassa T, Meca-Cortés O, Mateo F, Martínez de Paz A, Rubio N, Arnal-Estapé A, Ell BJ, Bermudo R, Díaz A, Guerra-Rebollo M, Lozano JJ, Estarás C, Ulloa C, Álvarez-Simón D, Milà J, Vilella R, Paciucci R, Martínez-Balbás M, de Herreros AG, Gomis RR, Kang Y, Blanco J, Fernández PL, Thomson TM.
    J Clin Invest; 2012 May 15; 122(5):1849-68. PubMed ID: 22505459
    [Abstract] [Full Text] [Related]

  • 9. Role of tissue transglutaminase 2 in the acquisition of a mesenchymal-like phenotype in highly invasive A431 tumor cells.
    Lin CY, Tsai PH, Kandaswami CC, Chang GD, Cheng CH, Huang CJ, Lee PP, Hwang JJ, Lee MT.
    Mol Cancer; 2011 Jul 21; 10():87. PubMed ID: 21777419
    [Abstract] [Full Text] [Related]

  • 10. EMT inducers catalyze malignant transformation of mammary epithelial cells and drive tumorigenesis towards claudin-low tumors in transgenic mice.
    Morel AP, Hinkal GW, Thomas C, Fauvet F, Courtois-Cox S, Wierinckx A, Devouassoux-Shisheboran M, Treilleux I, Tissier A, Gras B, Pourchet J, Puisieux I, Browne GJ, Spicer DB, Lachuer J, Ansieau S, Puisieux A.
    PLoS Genet; 2012 Jul 21; 8(5):e1002723. PubMed ID: 22654675
    [Abstract] [Full Text] [Related]

  • 11. Tissue transglutaminase constitutively activates HIF-1α promoter and nuclear factor-κB via a non-canonical pathway.
    Kumar S, Mehta K.
    PLoS One; 2012 Jul 21; 7(11):e49321. PubMed ID: 23185316
    [Abstract] [Full Text] [Related]

  • 12. Transamidase site-targeted agents alter the conformation of the transglutaminase cancer stem cell survival protein to reduce GTP binding activity and cancer stem cell survival.
    Kerr C, Szmacinski H, Fisher ML, Nance B, Lakowicz JR, Akbar A, Keillor JW, Lok Wong T, Godoy-Ruiz R, Toth EA, Weber DJ, Eckert RL.
    Oncogene; 2017 May 25; 36(21):2981-2990. PubMed ID: 27941875
    [Abstract] [Full Text] [Related]

  • 13. Activation of NF-κB by the RANKL/RANK system up-regulates snail and twist expressions and induces epithelial-to-mesenchymal transition in mammary tumor cell lines.
    Tsubaki M, Komai M, Fujimoto S, Itoh T, Imano M, Sakamoto K, Shimaoka H, Takeda T, Ogawa N, Mashimo K, Fujiwara D, Mukai J, Sakaguchi K, Satou T, Nishida S.
    J Exp Clin Cancer Res; 2013 Sep 05; 32(1):62. PubMed ID: 24011086
    [Abstract] [Full Text] [Related]

  • 14. Inflammatory factors of the tumor microenvironment induce plasticity in nontransformed breast epithelial cells: EMT, invasion, and collapse of normally organized breast textures.
    Leibovich-Rivkin T, Liubomirski Y, Bernstein B, Meshel T, Ben-Baruch A.
    Neoplasia; 2013 Dec 05; 15(12):1330-46. PubMed ID: 24403855
    [Abstract] [Full Text] [Related]

  • 15. Tissue transglutaminase induces Epithelial-Mesenchymal-Transition and the acquisition of stem cell like characteristics in colorectal cancer cells.
    Ayinde O, Wang Z, Griffin M.
    Oncotarget; 2017 Mar 21; 8(12):20025-20041. PubMed ID: 28223538
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Epithelial and mesenchymal subpopulations within normal basal breast cell lines exhibit distinct stem cell/progenitor properties.
    Sarrio D, Franklin CK, Mackay A, Reis-Filho JS, Isacke CM.
    Stem Cells; 2012 Feb 21; 30(2):292-303. PubMed ID: 22102611
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Mesenchymal gene program-expressing ovarian cancer spheroids exhibit enhanced mesothelial clearance.
    Davidowitz RA, Selfors LM, Iwanicki MP, Elias KM, Karst A, Piao H, Ince TA, Drage MG, Dering J, Konecny GE, Matulonis U, Mills GB, Slamon DJ, Drapkin R, Brugge JS.
    J Clin Invest; 2014 Jun 21; 124(6):2611-25. PubMed ID: 24762435
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.